FI49162C - Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives. - Google Patents

Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives.

Info

Publication number
FI49162C
FI49162C FI670074A FI7467A FI49162C FI 49162 C FI49162 C FI 49162C FI 670074 A FI670074 A FI 670074A FI 7467 A FI7467 A FI 7467A FI 49162 C FI49162 C FI 49162C
Authority
FI
Finland
Prior art keywords
indolyl
preparation
acid derivatives
aliphatic acid
therapeutically useful
Prior art date
Application number
FI670074A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Hisao Yamamoto
Masaru Nakao
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of FI49162C publication Critical patent/FI49162C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B19/00—Liquid-phase epitaxial-layer growth
    • C30B19/02—Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux
    • C30B19/04—Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux the solvent being a component of the crystal composition
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B19/00—Liquid-phase epitaxial-layer growth
    • C30B19/06—Reaction chambers; Boats for supporting the melt; Substrate holders
    • C30B19/061—Tipping system, e.g. by rotation
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/10—Inorganic compounds or compositions
    • C30B29/40—AIIIBV compounds wherein A is B, Al, Ga, In or Tl and B is N, P, As, Sb or Bi
    • C30B29/42—Gallium arsenide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydraulic Turbines (AREA)
FI670074A 1966-01-12 1967-01-12 Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives. FI49162C (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP199966 1966-01-12
JP2730066 1966-04-28
JP2730166 1966-04-28
JP2812566 1966-05-02
JP2840066 1966-05-04
JP4059166 1966-06-21
JP4472466 1966-07-08
JP4472366 1966-07-08
JP5467566 1966-08-19
JP5467466 1966-08-19

Publications (1)

Publication Number Publication Date
FI49162C true FI49162C (en) 1975-04-10

Family

ID=27579471

Family Applications (1)

Application Number Title Priority Date Filing Date
FI670074A FI49162C (en) 1966-01-12 1967-01-12 Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives.

Country Status (13)

Country Link
AT (4) AT283349B (en)
BE (1) BE692456A (en)
BR (1) BR6786134D0 (en)
CS (3) CS155157B2 (en)
DE (2) DE1620441C3 (en)
DK (1) DK134715B (en)
FI (1) FI49162C (en)
FR (1) FR7844M (en)
IL (1) IL27173A (en)
NL (1) NL146804B (en)
NO (3) NO126862B (en)
SE (2) SE314985B (en)
SU (1) SU375847A3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU162374B (en) * 1969-04-03 1973-02-28
CZ300116B6 (en) * 2006-12-05 2009-02-11 Zentiva, A. S. Purification process of (S)-N-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride

Also Published As

Publication number Publication date
NL6700300A (en) 1967-07-13
CS155157B2 (en) 1974-05-30
DE1620441B2 (en) 1974-09-19
SE314985B (en) 1969-09-22
BR6786134D0 (en) 1973-12-26
DE1618933A1 (en) 1972-03-16
NL146804B (en) 1975-08-15
SU375847A3 (en) 1973-03-23
CS155158B2 (en) 1974-05-30
DK134715B (en) 1977-01-03
DE1620441A1 (en) 1970-08-27
BE692456A (en) 1967-06-16
DE1643506B2 (en) 1973-01-04
AT283349B (en) 1970-08-10
NO126865B (en) 1973-04-02
DE1620441C3 (en) 1975-05-22
FR7844M (en) 1970-06-01
CS155156B2 (en) 1974-05-30
AT277995B (en) 1970-01-12
NO126862B (en) 1973-04-02
IL27173A (en) 1972-08-30
DK134715C (en) 1977-05-31
NO126864B (en) 1973-04-02
DE1643506A1 (en) 1972-03-30
AT277996B (en) 1970-01-12
SE307795B (en) 1969-01-20
AT280991B (en) 1970-05-11

Similar Documents

Publication Publication Date Title
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
FI49035C (en) Process for the preparation of therapeutically useful 2-bromo-alpha-gocryptine.
FI51046C (en) Process for the preparation of acetocalicylic acid tablet.
DK120749B (en) Analogous process for the preparation of 6-aminopenicillanic acid derivatives.
FI52335C (en) Process for the preparation of therapeutically active ethylamine derivatives.
FI46373C (en) A process for the preparation of new therapeutically useful derivatives of phenylaminopropane.
FI45447C (en) Process for the preparation of therapeutically active imidazole derivatives
FI47365C (en) Process for the preparation of new therapeutically active indolder t.
FI49512C (en) Process for the preparation of novel therapeutically active s-triazinyl-piperazine derivatives.
FI50409C (en) Process for the preparation of pyridine-carboxylic acids
FI48728C (en) Analogous process for the preparation of therapeutically useful phenylacetic acid derivatives.
FI45041C (en) Process for the preparation of therapeutically useful pyrrole derivatives.
FI46501C (en) Process for the preparation of therapeutically active, substituted phenylacetic acid esters.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI46154C (en) Process for the preparation of therapeutically useful diaminobentophenones and their acid addition salts.
FI46961C (en) Process for the preparation of therapeutically active 5-nitroimidazole bamates
FI47881C (en) Process for the preparation of therapeutically active substituted phenylacetamides
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI49308C (en) Process for the preparation of 6-aminopenicillanic acid.
FI49162C (en) Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives.
FI52577C (en) Process for the preparation of therapeutically useful phenazine derivatives.
FI47092C (en) Process for the preparation of therapeutically valuable mixture-substituted 1-phenoxy-3-alkylaminopropanols- (2).
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI45045C (en) Process for the preparation of novel therapeutically active 5-nitro-2-furyl-isoxazole derivatives.